Vanda Pharmaceuticals Inc. (VNDA), Thursday announced that it has received a revised proposal from Future Pak, LLC to takeover the company for $8.50-$9.00 per share in cash plus certain Contingent Value Rights.
The biopharmaceutical company added that the new proposal will be carefully reviewed and evaluated by the board before making a final decision.
Currently, Vanda's stock is moving up 13.20 percent, to $6.70 over the previous close of $5.92 on the Nasdaq.
For comments and feedback: editorial@rttnews.com